|Gene Therapy Virxsys VRX-496
Feb 1, 2006
Dear Dr. Pierone: In one of your answers about new medications, you said that vaccines and gene theraphy will be, someday, a revolution in HIV treament. I found something about VRX-496. Virxsys says in an "executive summary" that they have completed phase I and they will be using this gene therapy in 2006 as salvage therapy. That means over 10.000 patients a year. Is this true? Here is a link about VRX-496. http://www.virxsys.com/doc/VRX496PPM2003.pdf Thank you very much for your valuable time. John.
Response from Dr. Pierone
This company is engaged in gene therapy research directed against HIV. They have a candidate agent that is engineered to target CD4 cells and protect them against HIV. The have studied this in 5 humans and are enrolling phase II trials. This is an interesting approach and time will tell if it works or not. There are huge obstacles (and odds) for early experimental agents to overcome and this one is no exception.
If it does turn out to be effective in these small exploratory studies it will still be many years before larger numbers of patients will be treated. Gene therapy is one of the most promising areas of human biomedical research, but it is in its infancy and will take some time to come of age.
slow release meds
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.